Your browser doesn't support javascript.
loading
Access to Highly Enantioenriched Donepezil-like 1,4-Dihydropyridines as Promising Anti-Alzheimer Prodrug Candidates via Enantioselective Tsuji Allylation and Organocatalytic Aza-Ene-Type Domino Reactions.
Tîntas, Mihaela-Liliana; Azzouz, Rabah; Peauger, Ludovic; Gembus, Vincent; Petit, Emilie; Bailly, Laetitia; Papamicaël, Cyril; Levacher, Vincent.
Afiliação
  • Tîntas ML; Normandie Université , UNIROUEN, INSA Rouen, CNRS, COBRA, 76000 Rouen , France.
  • Azzouz R; VFP Therapies, R&D , 1 rue Tesnière , 76130 Mont Saint-Aignan , France.
  • Peauger L; VFP Therapies, R&D , 1 rue Tesnière , 76130 Mont Saint-Aignan , France.
  • Gembus V; VFP Therapies, R&D , 1 rue Tesnière , 76130 Mont Saint-Aignan , France.
  • Petit E; Normandie Université , UNIROUEN, INSA Rouen, CNRS, COBRA, 76000 Rouen , France.
  • Bailly L; Normandie Université , UNIROUEN, INSA Rouen, CNRS, COBRA, 76000 Rouen , France.
  • Papamicaël C; Normandie Université , UNIROUEN, INSA Rouen, CNRS, COBRA, 76000 Rouen , France.
  • Levacher V; Normandie Université , UNIROUEN, INSA Rouen, CNRS, COBRA, 76000 Rouen , France.
J Org Chem ; 83(17): 10231-10240, 2018 09 07.
Article em En | MEDLINE | ID: mdl-30004228
ABSTRACT
This work aims at exploiting both the enantioselective Tsuji allylation of allyl carbonate 6 and an organocatalytic aza-ene-type domino reaction between enal 3a and ß-enaminone 4a to develop a straightforward access to all of the four possible stereoisomers of a donepezil-like 1,4-dihydropyridine 1a (er up to 99.50.5; overall yield up 64%), an anti-Alzheimer's prodrug candidate. This strategy was extended to the preparation of other enantioenriched 1,4-dihydropyridines 1b-i (eight examples), highlighting its potential in the development of these chiral AChE inhibitors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidropiridinas / Pró-Fármacos / Doença de Alzheimer / Donepezila Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidropiridinas / Pró-Fármacos / Doença de Alzheimer / Donepezila Idioma: En Ano de publicação: 2018 Tipo de documento: Article